Large-scale testing (Phase 3)Study completedNCT02606461What this trial is testingSelinexor in Advanced LiposarcomaWho this might be right forDedifferentiated Liposarcoma Karyopharm Therapeutics Inc 342
Not applicableStudy completedNCT04560270What this trial is testingCIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic CancerWho this might be right forPancreatic CancerCirculating Tumor DNAKRAS Mutation-Related Tumors Poitiers University Hospital 69
Early research (Phase 1)Study completedNCT00276302What this trial is testingSafety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)Who this might be right forGastrointestinal Stromal TumorsSoft Tissue Sarcomas Infinity Pharmaceuticals, Inc. 63
Testing effectiveness (Phase 2)Study completedNCT05497843What this trial is testingChiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS)Who this might be right forSoft Tissue Sarcoma Chipscreen Biosciences, Ltd. 40
Early research (Phase 1)Study completedNCT00049023What this trial is testingRadiolabeled Octreotide in Treating Children With Advanced or Refractory Solid TumorsWho this might be right forBrain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more O'Dorisio, M S 27
Testing effectiveness (Phase 2)Study completedNCT01553539What this trial is testingTherapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By SurgeryWho this might be right forBone CancerChondrosarcomaClear Cell Sarcoma of the Kidney+9 more Wake Forest University Health Sciences 20
Testing effectiveness (Phase 2)Looking for participantsNCT05269381What this trial is testingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more Mayo Clinic 138
Testing effectiveness (Phase 2)Study completedNCT00390234What this trial is testingZiv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue SarcomaWho this might be right forFallopian Tube CancerFemale Reproductive CancerOvarian Carcinosarcoma+9 more National Cancer Institute (NCI) 63
Testing effectiveness (Phase 2)Looking for participantsNCT05019703What this trial is testingAtezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS StudyWho this might be right forLocally Advanced OsteosarcomaMetastatic OsteosarcomaRecurrent Osteosarcoma+2 more M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT06942442What this trial is testingA Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell SarcomaWho this might be right forHLA-A*0201 Positive Cells PresentClear Cell Sarcoma (CCS) Sarcoma Alliance for Research through Collaboration 47
Testing effectiveness (Phase 2)UnknownNCT04589754What this trial is testingAdriamycin and Ifosfamide Combined With SintilimabWho this might be right forSoft Tissue Sarcoma Sun Yat-sen University 176
Early research (Phase 1)Ended earlyNCT00003926What this trial is testingAmifostine to Protect From Side Effects of PSCT in Treating Patients With Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorChordoma+6 more Masonic Cancer Center, University of Minnesota 13
Testing effectiveness (Phase 2)WithdrawnNCT05174455What this trial is testingNiraparib for the Treatment of LeiomyosarcomaWho this might be right forLocally Advanced LeiomyosarcomaMetastatic LeiomyosarcomaStage III Retroperitoneal Sarcoma AJCC v8+4 more David Liebner, MD
Testing effectiveness (Phase 2)Looking for participantsNCT05894018What this trial is testingBrachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue SarcomaWho this might be right forSarcoma,Soft TissueBrachytherapyPoly(ADP-ribose) Polymerase Inhibitors Fujun Zhang 32
Testing effectiveness (Phase 2)Ended earlyNCT03074318What this trial is testingAvelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by SurgeryWho this might be right forMetastatic LeiomyosarcomaMetastatic LiposarcomaUnresectable Leiomyosarcoma+1 more Fred Hutchinson Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT00073983What this trial is testingGemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent ChondrosarcomaWho this might be right forSarcoma Sarcoma Alliance for Research through Collaboration 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT04458922What this trial is testingTesting Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced ChondrosarcomaWho this might be right forCentral Chondrosarcoma, Grade 2Central Chondrosarcoma, Grade 3Dedifferentiated Chondrosarcoma+3 more National Cancer Institute (NCI) 27
Early research (Phase 1)Study completedNCT00001577What this trial is testingPilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the ExtremityWho this might be right forMelanomaSarcoma National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT02300545What this trial is testingPazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for ChemotherapyWho this might be right forSarcoma, Soft TissueSoft Tissue Sarcoma Washington University School of Medicine 56
Early research (Phase 1)Study completedNCT02595866What this trial is testingTesting the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and CancerWho this might be right forAIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more National Cancer Institute (NCI) 58